Request a Quote
+1803294983432
customer.service@microbix.com
External Quality Controls
SARS Complete Panel
Respiratory Viral Panel
DxTM Viral Transport Medium
Custom Vial Filling Solutions
Proudly Supporting Over 100+ Customers with Leading Diagnostic Solutions
“Microbix approached us before the pandemic started, and the relationship developed so easily and quickly that we formalized our collaboration in 2020. Along with their excellent technical capabilities, they have successfully developed relationships with many diagnostics manufacturers around the world. We are pleased that our FLOQSwabs® are their exclusive choice for their growing line of swab formatted QAPs™”
Gaetano Natale, Chief Commercial Officer.
The Microbix Difference
Our Quality Commitment
By choosing Microbix Biosystems Inc., you are aligning with a partner certified to the latest ISO standards and dedicated to delivering products that truly set the benchmark for quality in the industry.
Decades of Expertise
With over three decades of experience in the global diagnostics industry, Microbix has established a reputation as a leading infectious disease diagnostic manufacturer.
Widespread Customer Acceptance
Microbix’s products have consistently earned widespread recognition and trust from customers due to their superior reliability.
Download Our Full Product Catalogue
News & Insights from Our Diagnostics Experts
-
Microbix Reports Continued Strong Results for Q3 Fiscal 2024
Microbix Biosystems Inc. reports results for its third quarter and first nine months of fiscal 2024 ended June 30, 2024 (“Q3” and “YTD”) with strong revenues, reflective of ongoing progress to increase sales from its diagnostic-test related ingredients and devices businesses and resulting in material net income for Q3 and YTD.
-
Microbix Schedules Release of Results for Q3 Fiscal 2024
Microbix Biosystems Inc. announces that it expects to file the financial statements and management disclosure and analysis for its third quarter of fiscal 2024 ended June 30, 2024 (“Q3 2024”) prior to the start of trading on August 14, 2024.
-
Microbix Presents HCV FLOQSwab® Format Test Control at ADLM
Microbix Biosystems Inc. introduces a novel Quality Assessment Product (QAP™) for Hepatitis C Virus (HCV) POCTs at the ADLM conference. This swab-based, room-temperature stable control aims to enhance accessibility and accuracy of HCV testing, especially in low-resource settings.
Speak to a Microbix Products Customer Service Representative
Let our knowledgeable experts help you secure your Microbix infectious disease diagnostics products supply today.